These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31985462)

  • 1. Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease.
    Ezzati A; Lipton RB;
    J Alzheimers Dis; 2020; 74(1):55-63. PubMed ID: 31985462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.
    Tam A; Laurent C; Gauthier S; Dansereau C
    J Prev Alzheimers Dis; 2022; 9(3):400-409. PubMed ID: 35841241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.
    Ezzati A; Zammit AR; Harvey DJ; Habeck C; Hall CB; Lipton RB;
    J Alzheimers Dis; 2019; 71(3):1027-1036. PubMed ID: 31476152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials.
    Ezzati A; Davatzikos C; Wolk DA; Hall CB; Habeck C; Lipton RB
    Alzheimers Dement (N Y); 2022; 8(1):e12223. PubMed ID: 35310531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter structure and derived network properties are used to predict the progression from mild cognitive impairment of older adults to Alzheimer's disease.
    Jiaxuan Peng ; Zheng G; Hu M; Zhang Z; Yuan Z; Xu Y; Shao Y; Zhang Y; Sun X; Han L; Gu X; Zhenyu Shu ;
    BMC Geriatr; 2024 Aug; 24(1):691. PubMed ID: 39160467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Landscape of Late-Phase Clinical Trials for Alzheimer's Disease: Comparing Regional Variation Between Subjects in Japan and North America.
    Kikuchi M; Adachi N; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2019 Dec; 33(6):511-518. PubMed ID: 31933241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
    Wang X; Li F; Tian J; Gao Q; Zhu H
    Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
    Irizarry MC; Webb DJ; Bains C; Barrett SJ; Lai RY; Laroche JP; Hosford D; Maher-Edwards G; Weil JG
    J Alzheimers Dis; 2008 Jul; 14(3):301-11. PubMed ID: 18599956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia.
    Tam A; Dansereau C; Iturria-Medina Y; Urchs S; Orban P; Sharmarke H; Breitner J; Bellec P;
    Gigascience; 2019 May; 8(5):. PubMed ID: 31077314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
    J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.